MeSH D010612 - pharyngitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Perrigo | Pseudoephedrine, Guaifenesin | Guaifenesin Pseudoephedrine |  | 2022-02-01 |  |  |
| Sanofi | Telithromycin | Ketek |  | 2001-07-09 |  |  |
| Telithromycin | Levviax |  | 2001-07-09 |  |  | |
| Aurobindo Pharma | Pseudoephedrine, Guaifenesin | Guaifenesin Pseudoephedrine |  | 2020-03-25 |  |  |
| Dr Reddys Laboratories | Pseudoephedrine, Guaifenesin | Guaifenesin Pseudoephedrine |  | 2017-12-29 |  |  |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
67%6/9
Phase 3
65%26/40
Approved: 10Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use